Limited treatment options are available for aggressive prostate cancer. Gossypol has been reported to have a potent anticancer activity in many types of cancer. It can increase the sensitivity of cancer cells to alkylating agents, diminish multidrug resistance and decrease metastasis. Whether or not it can induce autophagy in cancer cells has not yet been determined. Here we investigated the antiproliferative activity of apogossypolone (ApoG2) and (-)-gossypol on the human prostate cancer cell line PC3 and LNCaP in vitro. Exposure of PC-3 and LNCaP cells to ApoG2 resulted in several specific features characteristic of autophagy, including the appearance of membranous vacuoles in the cytoplasm and formation of acidic vesicular organelles. Expression of autophagy-associated LC3-II and beclin-1 increased in both cell lines after treatment. Inhibition of autophagy with 3-methyladenine promoted apoptosis of both cell types. Taken together, these data demonstrated that induction of autophagy could represent a defense mechanism against apoptosis in human prostate cancer cells.
Introduction
Cells encountering a variety of stresses undergo an evolutionarily conserved process of self-digestion termed autophagy. The importance of this intracellular damage response has been established in infectious diseases, neurodegeneration, heart failure and cancer [1] . In cancer, the debate continues as to whether or not autophagy is primarily a mechanism of cell death or cell survival. This is important to answer in order to promote the clinical development of therapeutic 698 npg interventions that can either inhibit or enhance autophagy in tumor cells. A number of clinically available cancer therapeutics, including DNA damaging chemotherapy, radiation therapy and molecularly targeted therapies, have been found to induce autophagy in cell culture and animal models [2] .
Autophagy has two conflicting functions in cell biology. It has been shown that hepatocellular carcinoma down-regulates autophagic activity [3, 4] , but recently, autophagy has been proposed as a tumor suppression mechanism, underlying the possibility that activation of autophagy reverses the neoplastic phenotype [5] . Cancer cells can respond to drugs by activating autophagy to promote cell survival, thus counteracting apoptosis [6] . Inhibition of autophagy would likely enhance apoptosis, indicating that autophagy contributes to tumor progression as a protective mechanism against stressful conditions [7, 8] . Longo et al. [9] reported that autophagy inhibition helped to enhance the chemopreventive/therapeutic activity of anthocyanin against hepatocellular carcinoma.
Prostate cancer is the most common malignancy and the second leading cause of cancer mortality in men. Unfortunately, there are limited treatment options available for this disease once primary therapies fail [10, 11] . Furthermore, an earlier diagnosis, which is necessary for surgery or irradiation is difficult to achieve [12] . Thus, newer therapies are badly needed.
The natural polyphenolic compound, gossypol, a promising male contraceptive drug candidate [13, 14] , has been reported to have potent anticancer activities [15, 16] . It has been shown to increase the sensitivity of cancer cells to alkylating agents [17] . Gossypol was also reported to be effective in treating multidrug-resistant cancer [18] . Furthermore, gossypol could decrease the metastasis of adrenal carcinoma, glioma and breast carcinoma [19] . Gossypol inhibits proliferation of MAT-LyLu Dunning prostate cancer cells in vitro, and also inhibits metastasis in xenografts [20] . In addition, gossypol inhibits proliferation or induces apoptosis of PC-3 human prostate cancer cells in vitro [20, 21] . (−)-Gossypol, the (−)-enantiomer of gossypol, also inhibits tumor growth in PC-3 xenografts, and sensitizes the anticancer effect of radiation therapy [21] .
It has been shown that gossypol induces apoptosis in PC-3 cells by modulating caspase-dependent and caspase-independent cell death pathways [22] . Apogossypolone (ApoG2) is a semi-synthesized derivative of gossypol that binds to the Bcl-2 family proteins in the low nanomolar range with a K i of 35 and 25 nmol L −1 for Bcl-2 and Mcl-1, respectively, and a K i of 660 nmol L −1 for Bcl-XL [23] . It has been proven that ApoG2 can be an effective therapeutic agent against follicular lymphoma by inducing apoptosis in a preclinical study [23] . ApoG2 has higher antitumor activity and lower toxicity than gossypol [24] . Whether or not it can induce autophagy in PC-3 and LNCaP prostate cancer cells remains unclear. The present study shows a novel response in PC-3 and LNCaP cells to ApoG2 involving the formation of acidic vesicular organelles (AVOs) and autophagy.
Materials and methods

Cell culture
PC-3 and LNCaP cells were purchased from the American Type Culture Collection (ATCC, Manassas, VA, USA). PC-3 cells were cultured in RPMI-1640 media (Gibco BRL, Grand Island, NY, USA) supplemented with 100 IU mL −1 penicillin G sodium, 100 mg mL −1 streptomycin sulfate and 10% (v/v) fetal bovine serum (Hyclone Laboratories, Logan, UT, USA). LNCaP cells were cultured in RPMI 1640 supplemented with 10% fetal bovine serum, 10 mmol L
HEPES, 1 mmol L −1 sodium pyruvate, 0.2% (w/v) glucose and antibiotics. Each cell line was maintained at 37ºC in a humidified incubator with 5% CO 2 .
Preparation of ApoG2 and (−)-gossypol
ApoG2 was synthesized by the College of Life Science and Technology of Xi'an Jiaotong University (Xi'an, China). Its purity was determined by high-pressure liquid chromatography analysis, showing a chemical purity of > 99%. (−)-Gossypol was purified at the College of Life Science and Technology of Xi'an Jiaotong University. Its chemical purity was > 98% with a chiral purity of > 97%. Stock solutions of 100 mg mL −1 ApoG2 and (−)-gossypol were prepared by dissolving ApoG2 or (−)-gossypol in 100% (v/v) dimethyl sulfoxide (DMSO) on the day of use. Working solutions were obtained by dilution of the stock solutions with culture medium.
MTT assay for cell growth and viability
Cell growth and viability were evaluated using the MTT assay (Sigma-Aldrich, St. Louis, MO, USA) [25] . PC-3 or LNCaP cells harvested from routine cultures were suspended in media and plated into 96-well microtiter plates at a density of 5 × 10 5 per well in a volume of 0.1 mL. After plating and incubation of the 3-MA. After exposure to the test drugs at 37ºC for 24, 48, 72 or 96 h, the cells were incubated with MTT for 4 h; the plates were processed and the absorbance (optical density) was detected as described by Romijn et al. [25] . Eight replicates were done for each experimental condition. The percentage of surviving cells was defined as mean absorbance of treated wells/mean absorbance of untreated wells.
Autophagy detection with acridine orange staining
As a marker of autophagy, the volume of the cellular acidic compartment was visualized by acridine orange (Molecular Probes, Eugene, OR, USA) staining [26] . In acridine orange-stained cells, the cytoplasm and nuclei fluoresce bright green and dim red, respectively, whereas the acidic compartment fluoresces bright red [27, 28] . The intensity of red fluorescence is proportional to the degree of acidity. Therefore, the volume of the cellular acidic compartment can be quantified [26, 27] . Cells were seeded in 96-well plates and treated as described above. At the various time points following treatment, cells were incubated with 1 mg L −1 acridine orange for 15 min. The dye was removed and fluorescence micrographs were taken using an inverted microscope equipped with a 100-W mercury lamp, 490-nm bandpass blue excitation filters, a 500-nm dichroic mirror and a 515-nm long-pass barrier filter. Autophage was quantified based on the mean number of cells displaying intense red staining in three fields (containing at least 50 cells per field) for each experiment condition.
Immunocytochemistry
PC-3 or LNCaP cells (10 5 ) were grown on coverslips and allowed to attach by overnight incubation. The cells were then exposed to DMSO or 5, 10 and 20 mg L ApoG2 or (−)-gossypol for the time periods mentioned above at 37ºC, washed with PBS and fixed at 4ºC overnight using 4% (w/v) paraformaldehyde. Subsequently, the cells were washed with PBS, and blocked with PBS containing 0.5% (w/v) bovine serum albumin (BSA) and 0.15% (w/v) glycine (BSA buffer) for 1 h at room temperature (RT). Cells were treated with rabbit anti-LC3-II (Abcam, Cambridge, UK) at 1:100 dilution in BSA buffer or rabbit anti-beclin-1 (Abcam) at 1:400 dilution in BSA buffer) for 1 h at RT. Cells were then washed with BSA buffer and incubated with FITC-conjugated goat anti-rabbit (Abcam) at 1:100 dilution in BSA buffer for 1 h at RT. Slides were mounted and examined under a fluorescence microscope (Olympus, Tokyo, Japan). Microtubule-associated protein 1A/1B-light chain 3 (LC3) is a soluble protein with a molecular mass of approximately 17 kDa distributed ubiquitously in mammalian tissues and cultured cells. During autophagy, autophagosomes engulf cytoplasmic components, including cytosolic proteins and organelles. Concomitantly, a cytosolic form of LC3 (LC3-I) is conjugated to phosphatidylethanolamine to form LC3-phosphatidylethanolamine conjugate (LC3-II), which is recruited to autophagosomal membranes. Autophagosomes fuse with lysosomes to form autolysosomes, and intraautophagosomal components are degraded by lysosomal hydrolases. At the same time, LC3-II in the autolysosomal lumen is degraded. Thus, lysosomal turnover of the autophagosomal marker LC3-II reflects autophagic activity, and detecting LC3-II by immunofluorescence has become a reliable method for monitoring autophagy and autophagyrelated processes. Beclin-1 was identified in a yeast twohybrid screen as a Bcl-2-interacting protein [29] . It has a key role in autophagy [30] [31] [32] [33] [34] , regulates the autophagypromoting activity of Vps34 [35] , and is involved in the formation of autophagosomes. Beclin 1 also interacts with Bcl-2, and may thus be involved in regulating cell death [29] . Luo and Rubinsztein [36] have proved that apoptosis induced by the proapoptotic protein Bax inhibited autophagy by enhancing caspase-mediated cleavage of Beclin-1. After cleavage, Beclin-1 does not interact with Vps34. It was shown that Bcl-2 binds to Beclin-1 to disrupt its autophagy function [37] .
Ultrastructure of treated PC-3 and LNCaP cells
Transmission electron microscopy (JEOL, Tokyo, Japan) was used to examine the effect of ApoG2 or (−)-gossypol treatment on PC-3 and LNCaP cells as described previously [38] . Briefly, PC-3 or LNCaP cells (2 × 10 5 ) were plated in six-well plates overnight, and were then treated with either DMSO (control) or 5, 10 and 20 mg L −1 ApoG2 or (−)-gossypol for 24, 48, 72 or 96 h at 37ºC. The cells were harvested by trypsinization, washed twice with PBS and fixed in 2.5% (w/v) ice-cold electron microscopy-grade glutaraldehyde in PBS (pH 7.3). The specimens were rinsed with PBS, postfixed in 1% (w/v) osmium npg tetroxide, dehydrated through a graded series of ethanol (30%-90%) and embedded in Epon 812 resin. Ultrathin 100-nm sections were cut using a LKB NOVA ultramicrotome (LKB-NOVA, Bromma, Sweden), stained with 2% (w/v) uranyl acetate and lead citrate, and examined on a JEM-2000EX transmission electron microscope (JEOL) at either × 4 000 or × 8 000 magnification.
Detection of apoptosis and autophagy by flow cytometry
The percentage of autophagic cell death was analyzed using flow cytometry with acridine orange staining according to published procedures [24] . Cells (2 × 10 
TUNEL assay
The method of Gavrieli et al. [40] was utilized as an independent assessment of apoptotic cell death. Adherent cells treated with 10 mg L −1 ApoG2 or (−)-gossypol were fixed and cells undergoing apoptosis were detected using the in situ cell death detection kit (Boehringer-Mannheim, Mannheim, Germany). For the apoptotic effects of 3-MA, 10 mmol L −1 3-MA was added to the culture before 10 mg L −1 ApoG2. The TUNEL assay was performed according to the manufacturer's instructions. Cells were then washed, mounted in vectashield mounting medium with Hoechst 33342 (Sigma-Aldrich) and photographed using the FV1000 laser scanning confocal microscope (Olympus). A positive control was prepared by treating a sample with DNaseI before TUNEL staining. For quantitative analysis, the percentage of TUNEL-positive cells among 200 cells in three fields per section was determined at × 200 magnification.
Statistical analysis
SPSS version 11.0 (SPSS Inc., Chicago, IL, USA) was used for all statistical analyses. All data were presented as mean ± SD. Statistical analysis was performed using the unpaired t-test. P < 0.05 was considered as statistically significant.
Results
ApoG2 and (−)-gossypol inhibited PC-3 and LNCaP cell growth
As shown in Figure 1A , (−)-gossypol inhibited PC-3 cell growth in a dose-dependent manner. In all, 20 mg L −1 (−)-gossypol showed the most significant growth inhibition on PC-3 cells, and the cell survival ratio was only 12% at 96 h. Similar growth inhibition of (−)-gossypol on LNCaP cells was observed. More than 85% LNCaP cells were lysed after 20 mg L −1 (−)-gossypol was administered for 96 h ( Figure 1B) . The inhibitory effect of ApoG2 on PC-3 and LNCaP cells was similar to that of (−)-gossypol and the dosedependent effect was also evident (Figures 1C and D) . The viability of cells treated with 3-MA also decreased in both cell lines, but just slightly (Figure 1 ). When both cell lines were treated with 3-MA and ApoG2, an enhanced growth inhibitory effect was observed (Figure 1 ).
(−)-Gossypol and ApoG2 induced apoptosis and autophagy in PC-3 and LNCaP
Translocation of PS from the internal side of the plasma membrane to the external occurs in the early stages of apoptosis. Annexin V is a Ca 2+ -dependent phospholipid-binding protein with high affinity for PS, and can be used as a sensitive probe for apoptosis. PS translocation is not unique to apoptosis and occurs npg also in necrosis. The difference between these two forms of cell death is that during the initial stages of apoptosis the cell membrane remains intact, while at the time of necrosis the cell membrane loses its integrity. Therefore, Annexin V binding as indicative of apoptosis has to be measured in conjunction with a dye exclusion test to assess cell membrane integrity. Figure 2D ). These data indicated that unlike (−)-gossypol, ApoG-2 induced apoptosis to a lesser extent.
When 3-MA was administered with ApoG2, the Figures 2C and D) . Co-treatment with 3-MA and 10 mg L -1 (−)-gossypol showed little effect on apoptosis (Figure 2A and 2B ). There was no significant effect on apoptosis by 3-MA alone (Figure 2 ). These results indicated that autophagy inhibition may serve to render cells susceptible to ApoG2-induced cell death.
AVOs and LC3-II were used to examine drug-treated PC-3 and LNCaP cells. As shown in Figures 2E and F ApoG2, the ratio of AVO decreased from 32.3% to 2.3% in PC-3 cells and from 28.9% to 3.2% in LNCaP cells (Figures 2E and F) . No significant difference in the ratio of AVO was found between control and 3-MA (Figure 2) . Here, increased levels of the autophagosomal marker LC3-II was detected by immunofluorescence after ApoG2 treatment, indicating the presence of autolysosomes or autophagolysosomes [41] .
Morphology of apoptosis and autophagy induced by (−)-gossypol and ApoG2 in PC-3 and LNCaP cells
As shown in Figures 3A-J , the upper pannels consisted of PC-3 cells and the lower pannels LNCaP cells. Upon treatment with 10 mg L −1 ApoG2, PC-3 ( Figure 3B ) or LNCaP ( Figure 3G ) cells showed negligible amounts of TUNEL-positive nuclei when compared with controls ( Figures 3A and 3F) , whereas PC-3 ( Figure 3C Figures 3D and I) . The number of TUNEL-positive nuclei in cells treated with 3-MA alone was similar to that of the DMSO group ( Figures 3E and J) . Cell counts were made according to the staining pattern ( Figure 3K ). The control group of PC-3 cells showed less apoptotic cell death than the ApoG2 group (1.2% ± 0.1% vs. 3.2% ± 0.3%), but the difference was not significant (P > 0.05). (−)-Gossypol induced significant increases in apoptotic cell death relative to control (P < 0.01). Results from LNCaP cells were similar. When 3-MA was added, the percentage of apoptotic cells induced by ApoG2 increased to 42.1% in PC-3 cells and to 45.6% in LNCaP cells, and this increase was significant (P < 0.01, Figure 3K ).
Electron microscopy was used to reveal the formation of autophagosomes in ApoG2-treated PC-3 cells. As shown in Figure 4A , DMSO-treated PC-3 cells exhibited large nuclei with prominent nucleoli, and uniform and finely dispersed chromatin. No autophagic vacuoles were observed, and microvilli were preserved on the cell surface. PC-3 cells treated for 24 h with 10 mg L −1 ApoG2 showed large vacuoles in the cytoplasm. Nuclei of these cells appeared normal with no sign of chromatin condensation. Formation of these vacuoles increased progressively with increasing ApoG2 exposure time. Some of the vacuoles resembled autophagosomes and contained remnants of degraded organelles ( Figure 4B) . At 72 h, microvilli were missing, the cytoplasm was filled with vacuoles, and the nuclei displayed chromatin condensation, characteristic of cells undergoing apoptosis ( Figure 4C ).
The ultrastructure of PC-3 cells treated with DMSO for 72 h appeared normal ( Figure 4D ). That of PC-3 cells treated for 24 h with 10 mg L −1 (−)-gossypol revealed no autophagic vacuoles. There was no microvilli swelling, and the nuclei showed chromatin condensation and DNA fragmentation ( Figure 4E ). The number of these cells increased progressively with increasing (−)-gossypol exposure. These results indicated that ApoG2 treatment caused formation of autophagosomelike structures, and that this cellular response occurred before the onset of apoptosis.
The effect of ApoG2 treatment on AVO formation in PC-3 cells was determined by fluorescence microscopy and acridine orange staining [42] . As shown in Figure  5A Figure  5D ). These results provided further evidence to indicate that ApoG2 treatment caused autophagy in PC-3 cells.
ApoG2 also induced autophagy in LNCaP cells
Unlike PC-3 cells, the LNCaP cell line is androgenresponsive and contains the wild-type p53. Like PC-3 cells, however, treatment of LNCaP cells with 10 mg L
−1
ApoG2 resulted in formation of autophagosome-like structures that were evident as early as 24 h ( Figure  6A ), and their number increased with exposure ( Figure  6B ). No such structures were observed in DMSOtreated PC-3 cells at 72 h ( Figure 6C ). In addition, ApoG2 treatment produced AVO in LNCaP cells, as revealed by acridine orange ( Figure 6D ). No AVO was detected in control ( Figure 6E ). Finally, similar to PC-3 cells, LNCaP cells with subdiploid DNA increased with ApoG2 treatment (data not shown) and cytoplasmic DNA fragmentation was significantly increased in the presence of 3-MA. Collectively, these results indicated that ApoG2-induced autophagy could be a common phenomenon and not restricted to any particular cell types.
Discussion
The present study shows that (−)-gossypol and ApoG2 inhibited growth of PC-3 and LNCaP cells in a time-and dose-dependent manner. The autophagy inhibitor 3-MA can enhance the growth-inhibitory effect of ApoG2 on both cell lines. The present study also provides experimental evidence to show activation of an autophagic program in human prostate cancer cells upon treatment with ApoG2, which is a highly promising nonpeptidic small-molecule inhibitor of Bcl-2. ApoG2-mediated autophagy in PC-3 and LNCaP cells is characterized by the appearance of membrane vacuoles containing remnants of mitochondria, and formation of AVOs. We also showed that the ApoG2-induced morphologic and biochemical changesassociated with autophagy preceded apoptosis. ApoG2-induced vacuoles and AVO were evident as early as 24 h npg after treatment and increased progressively with time, but the morphologic characteristics of apoptosis (e.g., chromatin condensation and DNA fragmentation) were not observed until 48 h later [43] .
The autophagic pathway is a novel therapeutic target for cancer treatment [5] [6] [7] 44] . Such anticancer treatments would activate autophagy to kill cancer cells resistant to apoptosis. Paglin et al. [26] were the first to show the possibility of treating cancer cells by demonstrating that cancer cells respond to radiation with inhibition of autophagy. Autophagy inhibition enhances the anticancer effect of arsenic trioxide, hyperthermia [6] , sulforaphane [45] , and p53 or alkylating drugs [2] . These and our observations indicate that autophagy protects cancer cells from therapy-induced apoptosis and that autophagy inhibitors improve the efficacy of proapoptotic chemotherapeutic strategies. Autophagy is also commonly induced by hypoxia, and it represents the last nutritional intake mechanism for tumor cells to survive under low-nutrient conditions [6] . Thus, suppression of autophagy in combination with other treatments could accelerate tumor death [8, 46] .
Cell death is subdivided into three categories: apoptosis (type I), autophagic cell death (type II) and necrosis (type III) [47] . Apoptosis is mediated by the activation of caspases and other factors released from the mitochondria. The molecular mechanism of apoptosis has been extensively studied, but that of autophagy is still obscure. The role of autophagy in cell death is controversial. Autophagy reportedly plays a protective role in allowing cells to survive during nutrient deprivation, and cells undergo apoptosis when autophagy is inhibited [48, 49] . However, the morphological features of autophagy have also been observed in dying cells in which caspases are suppressed or insufficiently activated [50, 51] . A more recent report demonstrated that oxidative stress-induced autophagic cell death is independent of apoptosis [52] , indicating that autophagy and apoptosis may occur independently of each other.
Although the connection between autophagy and apoptotic cell death is not clear, autophagy seems to promote apoptosis in some systems. For example, the formation of autophagosomes has been shown to be associated with TNF-α-induced apoptosis in human T lymphoblastic leukemia cells. In this model, inhibition of autophagy by 3-MA also inhibits DNA fragmentation [53] . More recently, Li et al. [54] have shown that 5-FU-induced apoptosis in colon cancer cells can be enhanced by 3-MA. Ding et al. [55] proved that inhibition by 3-MA enhanced apoptotic cell death induced by MG132 (a commonly used proteasome inhibitor) in not only Bax-positive HCT116 cells but also Bax-negative cells [55] . Shingu et al. [56] also found that the therapeutic efficacy of imatinib for malignant glioma might be augmented by 3-MA at a late stage, and that appropriate modulation of autophagy might sensitize tumor cells to anticancer therapy. Herman-Antosiewicz et al. [45] reported that autophagy represented a defense mechanism against sulforaphaneinduced apoptosis in human prostate cancer cells. This conclusion was based on the observations that sulforaphane-induced release of cytochrome c and apoptosis were significantly increased in the presence of 3-MA.
Apoptosis induction by certain sulforaphane analogs (e.g., phenethyl isothiocyanate) is regulated by p53 in some cells [57, 58] . For instance, mouse embryonic fibroblasts lacking p53 are resistant to phenethyl isothiocyanate-induced apoptosis compared to fibroblasts with p53 [58] . The present study suggests that p53 may not be required for ApoG2-induced autophagy or apoptosis because both PC-3 and LNCaP cells are sensitive to ApoG2-induced autophagy and apoptosis.
Formation of autophagosomes is a complex process regulated by multiple molecules [59, 60] . A cupshaped isolation membrane first forms around cytosolic components and it eventually fuses into a double membrane-bound vesicle. This autophagosome undergoes several microtubule-dependent maturation events, including fusion with endosomes and multilamellar vesicles, before fusion with lysosomes [61, 62] .
In conclusion, our observations indicate that apoptosis induction by ApoG2 in PC-3 and LNCaP human prostate cancer cells can be enhanced by inhibition of autophagy. This is the first published report to document activation of an autophagic program in the context of apoptosis by ApoG2. It is reasonable to speculate that autophagy inhibition may help to enhance the chemopreventive/therapeutic activity of ApoG2. We have shown that ApoG2 could significantly increase the life span of PC-3 and LNCaP prostate cancer-bearing nude mice. We also found that the hepatotoxicity and gastrointestinal toxicity of ApoG2 was lower than that of (−)-gossypol (data not shown). Therefore, ApoG2 could potentially be a more effective drug in the prostate cancer therapy. 
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